Organizers:
Marissa Renardy (Quantitative Systems Pharmacology, GSK), Kathryn G. Link, Quantitative Systems Pharmacology, Pfizer Inc.
Description:
Quantitative systems pharmacology (QSP) combines mathematical and computational modeling tools with mechanistic understanding of biology and pharmacology to guide drug discovery and development. QSP is used in the pharmaceutical industry to accelerate and de-risk drug discovery and development across multiple stages, from target discovery/validation to clinical trial design to lifecycle management. In recent years, QSP has been increasingly used in regulatory submissions for clinical trials across many therapeutic areas (PMID:34734497). In this session, speakers will present recent advances and perspectives in the field of QSP. This minisymposia will have two sessions. The first session will consist of four technical talks. The second session will be comprised of three technical talks and an industry panel discussion with prepared and audience-driven questions.
Farrah Sadre-Marandi
qPharmetra"Navigating pediatric dose selection: Insights from nifurtimox for Chagas disease"
Sarah Minucci
Certara"A Quantitative Systems Pharmacology Platform Model of Alzheimer's Disease for Reducing Amyloid Plaque and Tau"
Sarah Minucci, Olivia Walch, Farrah Sadre-Marandi, Marissa Renardy
Certara, Arcascope, qPharmetra, GSK"Industry Panel Discussion"
